(Q51551827)

English

Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes

scientific article published in October 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

type 2 diabetes

0 references

0 references

author name string

A H Cincotta

1

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

A H Meier

2

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

M Cincotta

3

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Expert Opinion on Investigational Drugs

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

8

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

10

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

1683-1707

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Novel therapeutic strategies for the treatment of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Properly timed injections of cortisol and prolactin produce long-term reductions in obesity, hyperinsulinaemia and insulin resistance in the Syrian hamster (Mesocricetus auratus).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Circadian neuroendocrine role in age-related changes in body fat stores and insulin sensitivity of the male Sprague-Dawley rat.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Role of liver in pathophysiology of NIDDM

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effects of Nonesterified Fatty Acids on Glucose Metabolism After Glucose Ingestion

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Genetics of NIDDM.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Kelly West Lecture 1991. Challenges in diabetes epidemiology--from West to the rest

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

A new world syndrome of metabolic diseases with a genetic and evolutionary basis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The thrifty genotype in non-insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Study on lipid metabolism in obesity diabetes.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Body fat and sympathetic nerve activity

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The hypothalamus, intrinsic connections and outflow pathways to the endocrine system in relation to the control of feeding and metabolism

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The hypothalamus and blood glucose regulation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5‐hydroxytryptamine1A receptor activation

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Role of central neural mechanisms in the regulation of hepatic glucose metabolism

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Maternal hormonal manipulations in rats cause obesity and increase medial hypothalamic norepinephrine release in male offspring

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Age- and diabetes-associated alterations in regional brain norepinephrine concentrations and adrenergic receptor populations in C57BL/KsJ mice

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Norepinephrine and dopamine levels in hypothalamic nuclei of the genetically obese mouse (ob/ob).

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effects of a quick-release form of bromocriptine (Ergoset) on fasting and postprandial plasma glucose, insulin, lipid, and lipoprotein concentrations in obese nondiabetic hyperinsulinemic women

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance in obese subjects

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Correlation of hyperprolactinemia with altered plasma insulin and glucagon: similarity to effects of late human pregnancy.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Prolactin: a diabetogenic hormone

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effect of bromocriptine on maturity onset diabetes

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

DENSITOMETRIC ANALYSIS OF BODY COMPOSITION: REVISION OF SOME QUANTITATIVE ASSUMPTIONS

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Effect of fatty acids on glucose production and utilization in man

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Mechanisms of fatty acid-induced inhibition of glucose uptake

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Dopaminergic Control of Circadian Norepinephrine Levels in Patients with Essential Hypertension

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The safety of bromocriptine in long-term use: a review of the literature

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

The safety of bromocriptine in hyperprolactinaemic female infertility: a literature review

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.10.1683

21 January 2018

Identifiers

10.1517/13543784.8.10.1683

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 April 2018

http://europepmc.org/abstract/MED/11139820

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51551827&oldid=2276828325"